CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 39 enrolled
Drug / intervention
Bifihappy +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03539263
NCT03539263N/ACompleted

Randomized Controlled Experimental Trial Designed to Test the Effects of Probiotics on Mood

Probiotical S.p.A.·interventional·Posted May 29, 2018·Updated May 29, 2018

In Brief

A clinical study evaluating Bifihappy and Placebo for Depression, Anxiety. Completed, enrolled 39 participants across 1 site.

Detailed Summary

Recent demonstration that probiotics administration has positive effects on depressive feelings in healthy populations suggests its possible role as an adjuvant therapy for depression in clinical populations and as a non-invasive strategy to prevent depressive feelings in healthy individuals. The present study extends current knowledge on the beneficial effects of probiotics on psychological well-being, as measured by changes in mood (e.g., depression, anxiety, cognitive reactivity to sad mood), personality dimensions, and quality of sleep, which have been considered as related to mood. For this double-blind, placebo-controlled study healthy volunteers pseudo-randomly assigned to an experimental or control group assumed a daily dose of probiotic or placebo, respectively, for 6 weeks. Mood, personality dimensions, and sleep quality were assessed four times (before the beginning of the study, at 3 and 6 weeks, and at 3 weeks of washout).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesItaly

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedMay 29, 2018
Enrollment StartDec 20, 2016
Primary CompletionJun 15, 2017
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 8.1 years ago

Interventions

Bifihappydietary

During the six weeks of treatment, the experimental group will take daily doses of 2,5 g with a concentration of 4x109 CFU/sachet of a mixture of lyophilised probiotic strains of the following species: * Lactobacillus fermentum * Lactobacillus rhamnosus * Lactobacillus plantarum * Bifidobacterium longum

Placeboother

During the six weeks of treatment, the experimental group will take daily doses of 2,5 g of maltodextrin